SEOUL, April 1 (Korea Bizwire) — South Korean drugmaker Medytox Inc. said Friday it has filed a complaint with a U.S. trade panel against domestic rival botox maker Hugel Inc. over a botulinum toxin strain. The complaint lodged with the U.S. International Trade Commission (ITC) targets top South Korean botox maker Hugel, its U.S. and [...]
SEOUL, Oct. 29 (Korea Bizwire) — A U.S. trade panel has invalidated its final ruling that sided with South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain dispute, company officials here said Friday. In December last year, the U.S. International Trade Commission (ITC) ordered a 21-month ban [...]
SEOUL, Oct. 7 (Korea Bizwire) — A U.S. court accepted a motion to dismiss a patent suit by South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain, company officials here said Thursday. Medytox had sued Daewoong in the Eastern District Court of Virginia and the Central District [...]
JUPITER, Fla., March 22 (Korea Bizwire) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics at flexible commercial scales, [...]
SEOUL, Dec. 17 (Korea Bizwire) — A U.S. trade panel has upheld its preliminary ruling by siding with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. copied the manufacturing process of a botulinum toxin strain, industry officials here said Thursday. In a final decision, the U.S. International [...]
SEOUL, July 7 (Korea Bizwire) — The U.S. International Trade Commission (ITC) has sided with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. stole secrets on a botulinum toxin strain, industry officials here said Tuesday. In its preliminary verdict, a U.S. trade judge on Monday (U.S. time) [...]
SEOUL, June 18 (Korea Bizwire) — South Korea’s drug safety watchdog said Thursday it has decided to revoke the permit of the country’s first botulinum toxin products by Medytox for using an unapproved ingredient and fabricating related documents. The three Meditoxin products — which come in bottles of 50 units, 100 units and 150 units [...]
SEOUL, May 20 (Korea Bizwire) — As the ‘war on botox strains’ is escalating between Medytox Inc. and Daewoong Pharmaceutical Co., the tension between the two companies is becoming worse day by day. Medytox has filed a complaint with the U.S. International Trade Commission (USITC), accusing Daewoong of stealing the company’s botox strains. Daewoong has [...]
SEOUL, Oct. 31 (Korea Bizwire) – South Korean pharmaceutical firms Medytox and Daewoong Pharmaceuticals are heading to court to settle a dispute surrounding the use of botulinum toxin, a highly poisonous substance used to make Botox, with the South Korean media branding the legal battle as the ‘Botox War’. According to Medytox on Monday, the pharmaceutical [...]
SEOUL, Oct. 14 (Korea Bizwire) – The market for botulinum toxin (BTX), commonly marketed as botox, is rapidly expanding in Korea. But fierce competition between Korean botox distributors has recently intensified, with businesses questioning the safety of each other’s products. There are currently seven BTX distributors globally, three of which are Korean – Medytox, Hugel, [...]